Mary S Beattie

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint Symptoms after breast cancer treatment: are they influenced by patient characteristics?
    Jean Yoon
    School of Public Health, Health Services, University of California at Los Angeles, Box 951772, Los Angeles, CA 90095 1722, USA
    Breast Cancer Res Treat 108:153-65. 2008
  2. pmc Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers
    Antonis C Antoniou
    Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Worts Causeway, Cambridge CB1 8RN, UK
    Breast Cancer Res 14:R33. 2012
  3. pmc Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance
    Patricia A Ganz
    Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles, CA 90095 6900, USA
    J Natl Cancer Inst 105:791-801. 2013
  4. pmc Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?
    Patricia A Ganz
    Department of Health Policy and Management, UCLA Fielding School of Public Health, Los sAngeles, CA, USA
    Brain Behav Immun 30:S99-108. 2013
  5. doi request reprint Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review
    Jessica Howard-Anderson
    David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095 6900, USA
    J Natl Cancer Inst 104:386-405. 2012
  6. doi request reprint Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer
    Patricia A Ganz
    School of Medicine, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA
    Menopause 15:797-803. 2008
  7. pmc Cancer survivorship research: the challenge of recruiting adult long term cancer survivors from a cooperative clinical trials group
    Patricia A Ganz
    School of Public Health and David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
    J Cancer Surviv 3:137-47. 2009
  8. pmc Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial
    Patricia A Ganz
    National Surgical Adjuvant Breast and Bowel Project Operations Center NSABP, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA
    J Clin Oncol 29:1110-6. 2011
  9. doi request reprint Survivorship: adult cancer survivors
    Patricia A Ganz
    David Geffen School of Medicine, UCLA, Los Angeles, CA, USA
    Prim Care 36:721-41. 2009
  10. pmc Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort
    Patricia A Ganz
    UCLA Schools of Public Health and Medicine, Jonsson Comprehensive Cancer Center, Los Angeles, CA 90095 6900, USA
    Breast Cancer Res Treat 129:549-56. 2011

Research Grants

  1. IMPROVING COLORECTAL CANCER SCREENING RATES
    Patricia Ganz; Fiscal Year: 2001
  2. BREAST CANCER--PREPARING FOR SURVIVORSHIP
    Patricia Ganz; Fiscal Year: 2002
  3. Cognitive Functioning After Breast Cancer Treatment
    Patricia Ganz; Fiscal Year: 2007
  4. Cognitive Functioning After Breast Cancer Treatment
    Patricia Ganz; Fiscal Year: 2009
  5. Cognitive Functioning After Breast Cancer Treatment
    Patricia A Ganz; Fiscal Year: 2010

Detail Information

Publications84

  1. ncbi request reprint Symptoms after breast cancer treatment: are they influenced by patient characteristics?
    Jean Yoon
    School of Public Health, Health Services, University of California at Los Angeles, Box 951772, Los Angeles, CA 90095 1722, USA
    Breast Cancer Res Treat 108:153-65. 2008
    ..This study examines the burden of symptoms by treatment type and patient characteristics in a population-based sample of newly diagnosed breast cancer patients...
  2. pmc Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers
    Antonis C Antoniou
    Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Worts Causeway, Cambridge CB1 8RN, UK
    Breast Cancer Res 14:R33. 2012
    ..2)...
  3. pmc Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance
    Patricia A Ganz
    Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles, CA 90095 6900, USA
    J Natl Cancer Inst 105:791-801. 2013
    ..Cognitive complaints are reported frequently after breast cancer treatments. Their association with neuropsychological (NP) test performance is not well-established...
  4. pmc Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?
    Patricia A Ganz
    Department of Health Policy and Management, UCLA Fielding School of Public Health, Los sAngeles, CA, USA
    Brain Behav Immun 30:S99-108. 2013
    ..These preliminary findings suggest that post-chemotherapy increases in TNF-α may be playing an important role in the manifestations of cognitive complaints in breast cancer survivors...
  5. doi request reprint Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review
    Jessica Howard-Anderson
    David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095 6900, USA
    J Natl Cancer Inst 104:386-405. 2012
    ....
  6. doi request reprint Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer
    Patricia A Ganz
    School of Medicine, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA
    Menopause 15:797-803. 2008
    ..Women at high risk of breast cancer should be offered this therapy, and if one drug is not well tolerated, the other should be considered...
  7. pmc Cancer survivorship research: the challenge of recruiting adult long term cancer survivors from a cooperative clinical trials group
    Patricia A Ganz
    School of Public Health and David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
    J Cancer Surviv 3:137-47. 2009
    ..Few adult cancer patients are treated on clinical trials; however, patients previously enrolled in these trials are an important source of information about treatment-related late effects...
  8. pmc Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial
    Patricia A Ganz
    National Surgical Adjuvant Breast and Bowel Project Operations Center NSABP, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA
    J Clin Oncol 29:1110-6. 2011
    ..The National Surgical Adjuvant Breast and Bowel Project B-30 trial included menstrual history (MH) and quality-of-life (QOL) studies to compare treatments on these outcomes...
  9. doi request reprint Survivorship: adult cancer survivors
    Patricia A Ganz
    David Geffen School of Medicine, UCLA, Los Angeles, CA, USA
    Prim Care 36:721-41. 2009
    ....
  10. pmc Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort
    Patricia A Ganz
    UCLA Schools of Public Health and Medicine, Jonsson Comprehensive Cancer Center, Los Angeles, CA 90095 6900, USA
    Breast Cancer Res Treat 129:549-56. 2011
    ..These observations need to be confirmed and suggest that greater attention should focus on the potential role of these commonly used medications in BC outcomes...
  11. pmc Physical and psychosocial recovery in the year after primary treatment of breast cancer
    Patricia A Ganz
    School of Public Health, University of California, Los Angeles, CA 90095, USA
    J Clin Oncol 29:1101-9. 2011
    ..The aim of this article is to characterize physical and psychosocial recovery as a function of chemotherapy receipt in the year after medical treatment completion...
  12. ncbi request reprint The impact of cancer and quality of life for long-term survivors
    Brad J Zebrack
    University of Southern California School of Social Work, Los Angeles, CA 90089 0411, USA
    Psychooncology 17:891-900. 2008
    ..This study reports on health status and quality of life (QOL) outcomes in long-term cancer survivors, and potential correlates including cancer type, age at diagnosis, health status, and key sociodemographic variables...
  13. ncbi request reprint Health-related quality of life in axillary node-negative, estrogen receptor-negative breast cancer patients undergoing AC versus CMF chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel Project B-23
    Stephanie R Land
    NSABP Biostatistical Center, Pittsburgh, USA Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA
    Breast Cancer Res Treat 86:153-64. 2004
    ..QOL information was considered especially relevant given the possibility that the two chemotherapy regimens would prove equivalent in terms of clinical outcome...
  14. doi request reprint Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial
    Sandra M Swain
    National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA
    Breast Cancer Res Treat 113:315-20. 2009
    ..These results can be used to inform premenopausal women about the risk and time course of amenorrhea associated with this common adjuvant therapy regimen, along with the effects on symptoms and QOL...
  15. ncbi request reprint Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1)
    Mary S Beattie
    Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, CA, USA
    J Natl Cancer Inst 98:110-5. 2006
    ..The purpose of this study was to determine whether sex hormone levels were associated with breast cancer risk and with response to tamoxifen in a high-risk population...
  16. ncbi request reprint Understanding cancer patients' experience and outcomes: development and pilot study of the Cancer Care Outcomes Research and Surveillance patient survey
    Jennifer L Malin
    Division of General Internal Medicine Health Services Research, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA
    Support Care Cancer 14:837-48. 2006
    ..The keystone to this effort is the baseline patient survey administered approximately 4 months after diagnosis...
  17. ncbi request reprint Inflammatory biomarkers for persistent fatigue in breast cancer survivors
    Alicia Collado-Hidalgo
    Cousins Center for Psychoneuroimmunology, University of California at Los Angeles Semel Institute for Neuroscience and Human Behavior, Los Angeles, California 90095 7076, USA
    Clin Cancer Res 12:2759-66. 2006
    ..This study seeks to define immunologic and inflammatory variables associated with persistent post-treatment fatigue in breast cancer survivors...
  18. pmc Variation in physician-patient discussion of breast reconstruction
    Judy Y Chen
    University of California, Los Angeles, CA, USA
    J Gen Intern Med 24:99-104. 2009
    ..This study examines sociodemographic variation of physician-patient discussion of breast reconstruction and explores the impact of this discussion on the use of breast reconstruction...
  19. doi request reprint The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal?
    Tammy M Beran
    Department of Psychology, UCLA, 1285 Franz Hall, Box 951563, Los Angeles, CA 90095 1563, USA
    Ann Behav Med 36:107-16. 2008
    ....
  20. pmc Assessing the impact of cancer: development of a new instrument for long-term survivors
    Brad J Zebrack
    University of Southern California School of Social Work, Los Angeles, CA 90089 0411, USA
    Psychooncology 15:407-21. 2006
    ..To develop and evaluate a new instrument that measures aspects of long-term survivorship not measured by existing tools...
  21. pmc Long-term prognostic role of functional limitations among women with breast cancer
    Dejana Braithwaite
    Helen Diller Family Comprehensive Cancer Center and the Department of Epidemiology and Biostatistics, University of California, San Francisco, 185 Berry St, Ste 5700, San Francisco, CA 94107, USA
    J Natl Cancer Inst 102:1468-77. 2010
    ..The long-term prognostic role of functional limitations among women with breast cancer is poorly understood...
  22. ncbi request reprint Obesity and cardiovascular risk factors in younger breast cancer survivors: The Cancer and Menopause Study (CAMS)
    Dena R Herman
    Division of Cancer Prevention and Control Research, UCLA Jonsson Comprehensive Cancer Center, A2 125 CHS, Box 956900, Los Angeles, CA, 90095 6900, USA
    Breast Cancer Res Treat 93:13-23. 2005
    ....
  23. ncbi request reprint Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial
    Stephanie R Land
    National Surgical Adjuvant Breast and Bowel Project NSABP Operations and Biostatistical Centers, Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA
    JAMA 295:2742-51. 2006
    ..Tamoxifen has been approved for breast cancer risk reduction in high-risk women, but how raloxifene compares with tamoxifen is unknown...
  24. pmc Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer
    Victor G Vogel
    NSABP, Pittsburgh, PA 15212, USA
    Cancer Prev Res (Phila) 3:696-706. 2010
    ..These results have important public health implications and clarify that both raloxifene and tamoxifen are good preventive choices for postmenopausal women with elevated risk for breast cancer...
  25. doi request reprint Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling
    Grace Wang
    Center for Translational and Policy Research on Personalized Medicine TRANSPERS, Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, USA
    Genet Med 13:1045-50. 2011
    ..We compared these policies with policies for breast cancer screening with magnetic resonance imaging to consider whether payers apply a unique policy approach to genetic services...
  26. doi request reprint Implementing a survivorship care plan for patients with breast cancer
    Patricia A Ganz
    Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, 650 Charles Young Dr South, Room A2 125 CHS, Los Angeles, CA 90095 6900, USA
    J Clin Oncol 26:759-67. 2008
    ..Providing the breast cancer treatment summary and survivorship care plan is being recognized as a key component of coordination of care that will foster the delivery of high-quality cancer care...
  27. pmc Facets of spirituality as predictors of adjustment to cancer: relative contributions of having faith and finding meaning
    Betina Yanez
    Department of Psychology, University of California, Los Angeles, CA 90095 1563, USA
    J Consult Clin Psychol 77:730-41. 2009
    ..Findings suggest that the ability to find meaning and peace in life is the more influential contributor to favorable adjustment during cancer survivorship, although faith appears to be uniquely related to perceived cancer-related growth...
  28. ncbi request reprint Use of patient-reported outcomes in phase III cancer treatment trials: lessons learned and future directions
    Patricia A Ganz
    University of California, Los Angeles Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA 90095 6900, USA
    J Clin Oncol 25:5063-9. 2007
    ..This article examines the challenges, opportunities, and successes that have occurred in the incorporation of patient-reported outcomes (PROs) in phase III cancer clinical trials...
  29. ncbi request reprint Application of assessing care of vulnerable elders-3 quality indicators to patients with advanced dementia and poor prognosis
    Neil S Wenger
    RAND Health, Santa Monica, CA 90407 2138, USA
    J Am Geriatr Soc 55:S457-63. 2007
    ..To use a formal decision-making strategy to reach clinically appropriate, internally consistent decisions on the application of quality indicators (QIs) to vulnerable elders (VEs) with advanced dementia (AD) or poor prognosis (PP)...
  30. ncbi request reprint Symptom management after breast cancer treatment: is it influenced by patient characteristics?
    Jean Yoon
    School of Public Health, Health Services Department, University of California at Los Angeles, Los Angeles, CA 90095 1772, USA
    Breast Cancer Res Treat 108:69-77. 2008
    ..We studied the extent to which symptoms for women with incident breast cancer are addressed by their physicians and how symptom management varies with patient characteristics...
  31. pmc Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer
    Julienne E Bower
    Department of Psychology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California 90095 1563, USA
    Clin Cancer Res 15:5534-40. 2009
    ....
  32. doi request reprint Validation of self-reported colorectal cancer (CRC) screening in a study of ethnically diverse first-degree relatives of CRC cases
    Roshan Bastani
    School of Public Health and Jonsson Comprehensive Cancer Center, University of California at Los Angeles School of Public Health, Los Angeles, CA 90095 6900, USA
    Cancer Epidemiol Biomarkers Prev 17:791-8. 2008
    ..Evidence about the accuracy of self-reports of colorectal cancer (CRC) screening is lacking. We conducted a validation protocol in a randomized trial to increase CRC screening among high-risk individuals...
  33. doi request reprint Quality-of-life issues in patients with ductal carcinoma in situ
    Patricia A Ganz
    Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, 650 Charles Young Dr South, Rm A2 125 CHS, Los Angeles, CA 90095 6900, USA
    J Natl Cancer Inst Monogr 2010:218-22. 2010
    ..Clinical and research efforts should focus on reducing the anxiety and psychological distress associated with the diagnosis of DCIS...
  34. pmc Fatigue and gene expression in human leukocytes: increased NF-κB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue
    Julienne E Bower
    UCLA Department of Psychology, 1285 Franz Hall, P O Box 951563, Los Angeles, CA 90095 1563, United States
    Brain Behav Immun 25:147-50. 2011
    ....
  35. doi request reprint Low-income women with abnormal breast findings: results of a randomized trial to increase rates of diagnostic resolution
    Roshan Bastani
    School of Public Health, Division of Cancer Prevention and Control Research, University of California Los Angeles, 650 Charles Young Drive South, Los Angeles, CA 90095, USA
    Cancer Epidemiol Biomarkers Prev 19:1927-36. 2010
    ..We report results of a randomized trial assessing the effectiveness of a patient support and navigation intervention in increasing timely diagnostic resolution of abnormal breast findings among indigent women...
  36. doi request reprint Ensuring quality care for cancer survivors: implementing the survivorship care plan
    Patricia A Ganz
    University of California, Los Angeles, CA 90095 6900, USA
    Semin Oncol Nurs 24:208-17. 2008
    ..Special attention is focused on the needs of childhood cancer survivors...
  37. pmc Refinement and psychometric evaluation of the impact of cancer scale
    Catherine M Crespi
    Division of Cancer Prevention and Control Research, UCLA School of Public Health and Jonsson Comprehensive Cancer Center, Los Angeles, CA 90095 6900, USA
    J Natl Cancer Inst 100:1530-41. 2008
    ....
  38. pmc Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors
    Catherine M Crespi
    Department of Biostatistics, School of Public Health, University of California Los Angeles, CHS 51 254, Box 951772, Los Angeles, CA, 90095 1772, USA
    J Cancer Surviv 4:45-58. 2010
    ..We compare measurement of the impact of cancer using the IOC instrument in breast cancer (BC) survivors (n = 1,188) and non-Hodgkin lymphoma (NHL) survivors (n = 652)...
  39. pmc Associations between single nucleotide polymorphisms in double-stranded DNA repair pathway genes and familial breast cancer
    Mary E Sehl
    Divisions of Hematology and Oncology and Geriatrics, Department of Medicine, David Geffen School of Medicine at University of California at Los Angeles, USA
    Clin Cancer Res 15:2192-203. 2009
    ..DNA damage recognition and repair play a major role in risk for breast cancer. We investigated 104 single nucleotide polymorphisms (SNP) in 17 genes whose protein products are involved in double-stranded break repair (DSBR)...
  40. doi request reprint Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897
    Patricia A Ganz
    School of Medicine, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, 650 Charles Young Dr South, Room A2 125 CHS, Los Angeles, CA 90095 6900, USA
    J Clin Oncol 26:1223-30. 2008
    ..The late cardiac effects of adjuvant anthracycline therapy in survivors of early-stage breast cancer have had limited study. Subclinical and clinical cardiac late effects may contribute to added comorbidity over time...
  41. ncbi request reprint Cancer related fatigue: a focus on breast cancer and Hodgkin's disease survivors
    Patricia A Ganz
    UCLA Schools of Medicine and Public Health, Los Angeles, California, USA
    Acta Oncol 46:474-9. 2007
    ....
  42. ncbi request reprint Estrogen, tamoxifen, and the brain
    Patricia A Ganz
    University of California at Los Angeles UCLA School of Medicine, and Jonsson Comprehensive Cancer Center at UCLA, 90095 6900, USA
    J Natl Cancer Inst 94:547-9. 2002
  43. ncbi request reprint Perceptions of positive meaning and vulnerability following breast cancer: predictors and outcomes among long-term breast cancer survivors
    Julienne E Bower
    Cousins Center for Psychoneuroimmunology, UCLA Neuropsychiatric Institute, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095 7076, USA
    Ann Behav Med 29:236-45. 2005
    ..Theoretical and descriptive accounts suggest that cancer may evoke both perceptions of vulnerability and positive meaning, with potentially different effects on mental health...
  44. ncbi request reprint Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue
    Julienne E Bower
    Cousins Center for Psychoneuroimmunology, UCLA Neuropsychiatric Institute, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Psychosom Med 67:277-80. 2005
    ..The purpose of the current study was to evaluate cortisol responses to an experimental psychologic stressor in fatigued and nonfatigued survivors...
  45. ncbi request reprint The BCPT symptom scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer
    Annette L Stanton
    Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center at UCLA, USA
    J Natl Cancer Inst 97:448-56. 2005
    ....
  46. ncbi request reprint Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen
    Steven A Castellon
    Department of Psychiatry and Biobehavioral Sciences, UCLA School of Medicine, Los Angeles, CA, USA
    J Clin Exp Neuropsychol 26:955-69. 2004
    ..We highlight ways in which these data converge with other recent studies to suggest that systemic chemotherapy, especially in combination with tamoxifen, can have adverse yet subtle effects on cognitive functioning...
  47. ncbi request reprint Does a history of childhood sexual abuse affect sexual outcomes in breast cancer survivors?
    Gail E Wyatt
    Department of Psychiatry and Behavioral Sciences, School of Medicine, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA 90095 6900, USA
    J Clin Oncol 23:1261-9. 2005
    ..As part of a larger survey study examining sexuality and intimacy in breast cancer survivors, we conducted in-person interviews with a subsample of participants...
  48. ncbi request reprint Diurnal cortisol rhythm and fatigue in breast cancer survivors
    Julienne E Bower
    Cousins Center for Psychoneuroimmunology, UCLA Neuropsychiatric Institute, Los Angeles, CA, USA
    Psychoneuroendocrinology 30:92-100. 2005
    ..g. depressed mood, body mass index). Results suggest a subtle dysregulation in hypothalamic-pituitary-adrenal axis functioning in breast cancer survivors with persistent fatigue...
  49. ncbi request reprint Association of breast cancer and its therapy with menopause-related symptoms
    Carolyn Crandall
    Division of General Internal Medicine, Jonsson Comprehensive Cancer Center, University of California at Los Angeles, 90095 7023, USA
    Menopause 11:519-30. 2004
    ..To study the relationship between current menopause status, occurrence of menopause transition during cancer treatment, and prevalence and severity of possible menopause-related symptoms...
  50. ncbi request reprint Primary care provider perceptions of barriers to and facilitators of colorectal cancer screening in a managed care setting
    Gareth S Dulai
    Division of Gastroenterology, Center for Ulcer Research and Education, Greater Los Angeles Veterans Administration Healthcare System, and Department of Medicine, School of Medicine, University of California Los Angeles, 90073, USA
    Cancer 100:1843-52. 2004
    ..The objectives of the current study were to describe current CRC screening practices and to explore determinants of test use by PCPs in a managed care setting...
  51. ncbi request reprint Breast cancer in younger women: reproductive and late health effects of treatment
    Patricia A Ganz
    University of California Los Angeles Schools of Medicine and Public Health, USA
    J Clin Oncol 21:4184-93. 2003
    ..In 1997, we initiated a cohort study to evaluate quality of life (QOL) and reproductive health outcomes in younger female breast cancer survivors. Materials and..
  52. ncbi request reprint Breast cancer in older women: quality of life and psychosocial adjustment in the 15 months after diagnosis
    Patricia A Ganz
    University of California, School of Medicine and Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, 90095 6900, USA
    J Clin Oncol 21:4027-33. 2003
    ..We examined the health-related quality of life (QOL) of a cohort of older women with breast cancer after their diagnosis...
  53. ncbi request reprint Improving colorectal cancer screening rates in a managed care health plan: recruitment of provider organizations for a randomized effectiveness trial
    Patricia A Ganz
    Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, School of Medicine, University of California, Los Angeles, California 90095 6900, USA
    Cancer Epidemiol Biomarkers Prev 12:824-9. 2003
    ..Successful implementation of programs that are feasible and take advantage of existing quality improvement mechanisms within the PO has potential to improve CRC screening rates and can have a major public health impact...
  54. ncbi request reprint Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133
    Patricia A Ganz
    University of California, Los Angeles, Los Angeles, CA, USA
    J Clin Oncol 21:3512-9. 2003
    ....
  55. ncbi request reprint T-cell homeostasis in breast cancer survivors with persistent fatigue
    Julienne E Bower
    Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, UCLA Neuropsychiatric Institute, CA 90095 7076, USA
    J Natl Cancer Inst 95:1165-8. 2003
    ..These results require confirmation in a larger study that is specifically designed to address this hypothesis...
  56. ncbi request reprint Continuing education: Comprehensive menopausal assessment: an approach to managing vasomotor and urogenital symptoms in breast cancer survivors
    Laura Zibecchi
    Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA, USA
    Oncol Nurs Forum 30:393-407. 2003
    ..To describe the development and implementation of a comprehensive menopausal assessment (CMA) and intervention program for women with a history of breast cancer...
  57. ncbi request reprint Fatigue and proinflammatory cytokine activity in breast cancer survivors
    Julienne E Bower
    Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles 90095 6900, USA
    Psychosom Med 64:604-11. 2002
    ..Differences in lymphocyte subsets, cortisol, and behavioral symptoms associated with proinflammatory cytokines were also assessed...
  58. ncbi request reprint What outcomes matter to patients: a physician-researcher point of view
    Patricia A Ganz
    Division of Cancer Prevention and Control Research, UCLA Schools of Medicine and Public Health, Jonsson Comprehensive Cancer Center, Los Angeles, California 90095 6900, USA
    Med Care 40:III11-9. 2002
    ..This has become increasingly relevant in the treatment of cancer, where patients are confronted with a life-threatening illness and may have varied treatment choices and outcomes...
  59. ncbi request reprint Validity of cancer registry data for measuring the quality of breast cancer care
    Jennifer L Malin
    Divisions of General Internal Medicine Health Services Research, and Hematology Oncology, Department of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles 90095 1736, USA
    J Natl Cancer Inst 94:835-44. 2002
    ..The validity of cancer registry data for quality of cancer care has not been well studied. We investigated the validity of such information in the California Cancer Registry...
  60. ncbi request reprint Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study
    Patricia A Ganz
    School of Medicine, University of California, Los Angeles 90095 6900, USA
    J Natl Cancer Inst 94:39-49. 2002
    ..Women with breast cancer are the largest group of female survivors of cancer. There is limited information about the long-term quality of life (QOL) in disease-free breast cancer survivors...
  61. ncbi request reprint Outcomes from the Moving Beyond Cancer psychoeducational, randomized, controlled trial with breast cancer patients
    Annette L Stanton
    Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center at University of California, Los Angeles, USA
    J Clin Oncol 23:6009-18. 2005
    ..To facilitate the transition to recovery, we conducted the Moving Beyond Cancer (MBC) trial, a multisite, randomized, controlled trial of psychoeducational interventions for breast cancer patients...
  62. ncbi request reprint Contextual life stress and coping strategies as predictors of adjustment to breast cancer survivorship
    Carissa A Low
    Department of Psychology, University of California, Los Angeles, CA 90095, USA
    Ann Behav Med 32:235-44. 2006
    ....
  63. ncbi request reprint Pro-inflammatory cytokines and depression in a familial cancer registry
    Mary Frances O'Connor
    Cousins Center for Psychoneuroimmunology, UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA 90095 7076, USA
    Psychooncology 16:499-501. 2007
    ..The present data are important for characterizing persons at high risk for cancer who may later acquire knowledge of further increased risk through genetic testing...
  64. ncbi request reprint Monitoring the physical health of cancer survivors: a survivorship-focused medical history
    Patricia A Ganz
    University of California, Los Angeles, Schools of Medicine and Public Health, Los Angeles, CA, USA
    J Clin Oncol 24:5105-11. 2006
    ..This article provides guidance on how to take a cancer survivor-directed medical history to facilitate the elicitation of relevant exposures, family history, and symptoms that may be related to the late effects of cancer therapy...
  65. ncbi request reprint Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy
    Daniel H S Silverman
    Department of Molecular and Medical Pharmacology, University of California, David Geffen School of Medicine, Los Angeles, CA 90095 6942, USA
    Breast Cancer Res Treat 103:303-11. 2007
    ..To explore the relationship of regional cerebral blood flow and metabolism with cognitive function and past exposure to chemotherapy for breast cancer...
  66. ncbi request reprint Inflammatory responses to psychological stress in fatigued breast cancer survivors: relationship to glucocorticoids
    Julienne E Bower
    Cousins Center for Psychoneuroimmunology, Semel Institute for Neuroscience at UCLA, 300 UCLA Medical Plaza, Room 3306, Box 957076 Los Angeles, CA 90095 7076, USA
    Brain Behav Immun 21:251-8. 2007
    ..05). These data provide further evidence of enhanced inflammatory processes in fatigued breast cancer survivors and suggest that these processes may stem in part from decreased glucocorticoid response to stress...
  67. pmc Financial incentives for quality in breast cancer care
    Diana M Tisnado
    Department of Medicine, University of California, Los Angeles, 911 Broxton Plz, Los Angeles, CA 90095 1736, USA
    Am J Manag Care 14:457-66. 2008
    ....
  68. ncbi request reprint The role of prevention in oncology practice: results from a 2004 survey of American Society of Clinical Oncology members
    Patricia A Ganz
    Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center at UCLA, University of California, Los Angeles UCLA School of Medicine, Los Angeles, CA 90095 6900, USA
    J Clin Oncol 24:2948-57. 2006
    ..In 2004, the American Society of Clinical Oncology (ASCO) Cancer Prevention Committee surveyed the members to describe involvement in clinical prevention activities...
  69. ncbi request reprint Breast cancer, menopause, and long-term survivorship: critical issues for the 21st century
    Patricia A Ganz
    Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, UCLA Schools of Medicine and Public Health, University of California Los Angeles, Los Angeles, California, USA
    Am J Med 118:136-41. 2005
    ..Thus, this special population of women requires unique management strategies and deserves separate consideration...
  70. ncbi request reprint Fatigue in long-term breast carcinoma survivors: a longitudinal investigation
    Julienne E Bower
    Cousins Center for Psychoneuroimmunology, Semel Institute for Neuroscience, University of California at Los Angeles, 90095, USA
    Cancer 106:751-8. 2006
    ..A longitudinal study was designed to evaluate the prevalence, persistence, and predictors of posttreatment fatigue in breast carcinoma survivors...
  71. ncbi request reprint Promoting adjustment after treatment for cancer
    Annette L Stanton
    Department of Psychology, 1285 Franz Hall, Box 951563, University of California Los Angeles, 90095 1563, USA
    Cancer 104:2608-13. 2005
    ..Promising psychosocial interventions have been developed for individuals in the reentry period. Continued research will be necessary to characterize this important phase of cancer survivorship...
  72. ncbi request reprint Breast cancer treatment and cognitive functioning: current status and future challenges in assessment
    Steven A Castellon
    Greater Los Angeles VA Healthcare System, Los Angeles, CA, USA
    Breast Cancer Res Treat 92:199-206. 2005
  73. ncbi request reprint Results of a randomized controlled trial to increase colorectal cancer screening in a managed care health plan
    Patricia A Ganz
    Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California 90095 6900, USA
    Cancer 104:2072-83. 2005
    ..A quality improvement (QI) program to increase CRC screening was developed for use in a managed care health plan...
  74. ncbi request reprint Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial
    Victor G Vogel
    Magee Womens Hospital, University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213 3221, USA
    JAMA 295:2727-41. 2006
    ..Tamoxifen is approved for the reduction of breast cancer risk, and raloxifene has demonstrated a reduced risk of breast cancer in trials of older women with osteoporosis...
  75. pmc The half century of clinical trials of the National Surgical Adjuvant Breast And Bowel Project
    D Lawrence Wickerham
    NSABP Operations Office, Biostatistical Center and Graduate School of Public Health, University of Pittsburgh, and Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA 15212, USA
    Semin Oncol 35:522-9. 2008
    ....
  76. ncbi request reprint Compliance with patient-reported outcomes in multicenter clinical trials: methodologic and practical approaches
    Stephanie R Land
    National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistical Centers, Pittsburgh, PA 15213, USA
    J Clin Oncol 25:5113-20. 2007
    ..We describe the effectiveness of several interventions and of observational factors...
  77. pmc Clinical and biomarker predictors of side effects from tamoxifen
    Wendy Lorizio
    Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA
    Breast Cancer Res Treat 132:1107-18. 2012
    ..The association between endoxifen levels and side effects is consistent with the data that suggest that endoxifen is the most highly active metabolite of tamoxifen...
  78. pmc Pre-counseling education for low literacy women at risk of Hereditary Breast and Ovarian Cancer (HBOC): patient experiences using the Cancer Risk Education Intervention Tool (CREdIT)
    Galen Joseph
    Department of Anthropology, History, and Social Medicine, University of California, San Francisco, San Francisco, CA 94143 0128, USA
    J Genet Couns 19:447-62. 2010
    ..In addition, the implementation of CREdIT in diverse clinical settings and the cultural adaptation of CREdIT to specific populations reflect important areas for future work...
  79. doi request reprint Family communication of BRCA1/2 results and family uptake of BRCA1/2 testing in a diverse population of BRCA1/2 carriers
    Julia Fehniger
    Cancer Risk Program, University of California, San Francisco, San Francisco, CA, USA
    J Genet Couns 22:603-12. 2013
    ..Addressing these disparities will require further research into the best ways to facilitate family communication and counsel at-risk relatives of racially and socioeconomically diverse BRCA1/2 mutation carriers...
  80. pmc Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations
    Daniel H Kim
    School of Medicine, University of California San Francisco, San Francisco, CA 94115, USA
    Fam Cancer 8:153-8. 2009
    ..0014 for BRCA1 and P = 0.011 for BRCA2 by unpaired t-test). Our findings suggest that families with early onset pancreatic cancer and features of hereditary breast and ovarian cancer should be considered for BRCA1/2 testing...
  81. pmc Fecal incontinence in females older than aged 40 years: who is at risk?
    Madhulika G Varma
    Department of Surgery, University of California, San Francisco, San Francisco, California 94115, USA
    Dis Colon Rectum 49:841-51. 2006
    ..This study was designed to estimate the prevalence of, and identify risk factors associated with, fecal incontinence in racially diverse females older than aged 40 years...
  82. doi request reprint Risk-reducing salpingo-oophorectomy and ovarian cancer screening in 1077 women after BRCA testing
    Gabriel N Mannis
    Division of Hematology Oncology, Department of Internal Medicine, University of California, San Francisco, 505 Parnassus Ave, Room M1286, San Francisco, CA 94117, USA
    JAMA Intern Med 173:96-103. 2013
    ..We surveyed a large cohort of women after BRCA testing to identify the prevalence and posttest predictors of risk-reducing and screening interventions...
  83. pmc The structural landscape of the health care system for breast cancer care: results from the Los Angeles Women's Health Study
    Diana M Tisnado
    Division of General Internal Medicine and Health Services Research, School of Medicine, University of California, Los Angeles, California 90095 1736, USA
    Breast J 15:17-25. 2009
    ..Data from this study represent important building blocks for further analyses to determine the impact of structural characteristics on the quality of care that breast cancer patient's experience...

Research Grants23

  1. IMPROVING COLORECTAL CANCER SCREENING RATES
    Patricia Ganz; Fiscal Year: 2001
    ..Finally, we will establish the validity of member self-report of FOBT and sigmoidoscopy through a chart review. ..
  2. BREAST CANCER--PREPARING FOR SURVIVORSHIP
    Patricia Ganz; Fiscal Year: 2002
    ....
  3. Cognitive Functioning After Breast Cancer Treatment
    Patricia Ganz; Fiscal Year: 2007
    ....
  4. Cognitive Functioning After Breast Cancer Treatment
    Patricia Ganz; Fiscal Year: 2009
    ....
  5. Cognitive Functioning After Breast Cancer Treatment
    Patricia A Ganz; Fiscal Year: 2010
    ....